Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
This article reports an in vitro study of microneedle-array-enhanced transdermal transport of model drug compounds dispersed in chitosan films. Each microneedle array has 400 out-of-plane, needle-shaped microstructures fabricated using micro-electro-mechanical systems (MEMS) technology to ensure adequate mechanical strength and high precision, and consistency. A nanometer coating on the microneedles ensured the biocompatibility that is important in the application of transdermal drug delivery. Model drugs selected to investigate skin permeation in vitro were calcein, a small molecule (molecular weight, 623 d) that has little skin penetration, and bovine serum albumin (BSA) (molecular weight, 66,000 d), a hydrophilic biological macromolecule. A Franz permeation cell was used to characterize the permeation rate of calcein and BSA through the rat skin. The transdermal transport behavior of BSA was investigated from solid films coated on the surface of microneedle arrays with various chitosan concentrations, film thicknesses, and BSA contents. The BSA permeation rate decreased with the increase of the chitosan concentration; the thicker the film, the slower the permeation rate. In addition, the permeation rate increased with the increase of BSA loading dose. A linear relationship existed between the permeation rate and the square root of the BSA loading dose. Results showed that the chitosan hydrophilic polymer film acts as a matrix that can regulate the BSA release rate. The controlled delivery of BSA can be achieved using the BSA-containing chitosan matrix film incorporated with the microneedle arrays. This will provide a possible way for the transdermal delivery of macromolecular therapeutic agents such as proteins and vaccines.
Xie
Yu
Y
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China.
Xu
Bai
B
Gao
Yunhua
Y
D000042:Absorption; D000818:Animals; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry; D004058:Diffusion; D004867:Equipment Design; D019544:Equipment Failure Analysis; D066298:In Vitro Techniques; D007279:Injections, Subcutaneous / Q000295:instrumentation* / Q000379:methods; D008297:Male; D044085:Microfluidics / Q000295:instrumentation* / Q000379:methods; D008845:Microinjections / Q000295:instrumentation* / Q000379:methods; D008904:Miniaturization; D009339:Needles; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000737:chemistry*; D012869:Skin Absorption
D003692:Delayed-Action Preparations; D004364:Pharmaceutical Preparations